Procarbazine
Showing 1 - 25 of 105
Primary CNS Lymphoma Trial in Moscow (Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide)
Recruiting
- Primary CNS Lymphoma
- Rituximab, Methotrexate, Vincristine, Procarbazine, Lenalidomide
-
Moscow, Russian FederationNathional Medical Research Center for Hematology
Jun 16, 2022
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,
Active, not recruiting
- CNS Lymphoma
- +2 more
- Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
-
Basking Ridge, New Jersey
- +2 more
Jan 27, 2023
Brain and CNS Tumors Trial in United States (procarbazine HCl, thalidomide)
Completed
- Brain and Central Nervous System Tumors
- procarbazine hydrochloride
- thalidomide
-
Decatur, Illinois
- +4 more
Sep 7, 2021
AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell
Completed
- AIDS-related Diffuse Large Cell Lymphoma
- +8 more
- cyclophosphamide
- +7 more
-
Eldoret, Kenya
- +1 more
Sep 12, 2022
Lymphoma, Large B-Cell, Diffuse, CNS Tumors, Primary Trial in France (Lenalidomide, Ibrutinib)
Recruiting
- Lymphoma, Large B-Cell, Diffuse
- Central Nervous System Neoplasms, Primary
-
Amiens, France
- +26 more
Nov 30, 2022
Primary CNS Lymphoma Trial in Worldwide (Rituximab, Methotrexate, Procarbazine)
Recruiting
- Primary Central Nervous System Lymphoma
- Rituximab
- +5 more
-
Aarhus, Denmark
- +34 more
Nov 4, 2022
Oligodendroglioma Trial in Germany (CETEG, PCV, RT)
Recruiting
- Oligodendroglioma
- CETEG
- +2 more
-
Heidelberg, Baden-Württemberg, Germany
- +18 more
Sep 22, 2022
Lymphoma Trial in Southampton (bleomycin sulfate, filgrastim, pegfilgrastim)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +10 more
-
Southampton, England, United KingdomSouthampton General Hospital
Apr 27, 2021
Lymphoma Trial (biological, drug, radiation)
Active, not recruiting
- Lymphoma
- bleomycin sulfate
- +7 more
- (no location specified)
Feb 2, 2021
Lymphoma Trial in Houston (Fludarabine, Novantrone, Decadron)
Completed
- Lymphoma
- Fludarabine
- +14 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 22, 2020
Brain and CNS Tumors Trial (lomustine, procarbazine HCl, vincristine sulfate)
Completed
- Brain and Central Nervous System Tumors
- lomustine
- +3 more
- (no location specified)
Oct 15, 2020
Hodgkin Lymphoma Trial in Spain (BrentuximabVedotin (BV))
Active, not recruiting
- Hodgkin Lymphoma
- BrentuximabVedotin (BV)
-
Badalona, Barcelona, Spain
- +14 more
Aug 12, 2020
Hodgkin Lymphoma Trial in France (brentuximab vedotin, Cyclophosphamide, Adriamycin)
Completed
- Hodgkin Lymphoma
- brentuximab vedotin
- +9 more
-
Argenteuil, France
- +29 more
Jul 23, 2021
Classic Hodgkin Lymphoma Trial (procedure, biological, drug, other, radiation)
Not yet recruiting
- Classic Hodgkin Lymphoma
- Biospecimen Collection
- +19 more
- (no location specified)
Jan 6, 2023
Hodgkin Lymphoma Trial in Cologne (BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine,
Completed
- Hodgkin Lymphoma
- BEACOPPescalated (Bleomycin, Etoposide, Adriamycin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone)
- +3 more
-
Cologne, Germany1st Dept. of Medicine, Cologne University Hospital
Apr 3, 2020
Part A: Relapsed or Refractory Primary CNS Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL Trial in United
Recruiting
- Part A: Relapsed or Refractory Primary Central Nervous System Lymphoma (PCNSL), Part B: Newly Diagnosed, Treatment naïve PCNSL
-
Duarte, California
- +29 more
Jun 15, 2022
Lymphoma Trial in Worldwide (bleomycin sulfate, filgrastim, pegfilgrastim)
Completed
- Lymphoma
- bleomycin sulfate
- +12 more
-
Garran, Australian Capital Territory, Australia
- +139 more
Dec 19, 2022
Hodgkin Lymphoma Trial in Copenhagen (ABVD + FDG-PET/CT Scan treatment adaptation, BEACOPPesc)
Withdrawn
- Hodgkin Lymphoma
- ABVD + FDG-PET/CT Scan treatment adaptation
- BEACOPPesc
-
Copenhagen, DenmarkRigshospitalet
Feb 11, 2021
Oligodendroglioma, Low-grade Oligodendroglioma, 1p19q Codeletion Trial in France (PCV chemo, Radiotherapy and PCV chemo)
Recruiting
- Oligodendroglioma
- +2 more
- PCV chemotherapy
- Radiotherapy and PCV chemotherapy
-
Amiens, France
- +25 more
Jun 14, 2022
Primary CNS Lymphoma Trial in Paris ([18F]-FDG PET/MR)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- [18F]-FDG PET/MR
-
Paris, FrancePitié Salpêtrière Hospital
Sep 9, 2021
Primary CNS Lymphoma Trial in Paris (Rituximab, Methotrexate, Temozolomide)
Active, not recruiting
- Primary Central Nervous System Lymphoma
- Rituximab, Methotrexate, Temozolomide
-
Paris, FranceGroupe Hospitalier Pitie Salpetriere
Feb 10, 2022
Lymphoma Trial in Worldwide (biological, drug, radiation)
Unknown status
- Lymphoma
- bleomycin sulfate
- +9 more
-
Antwerp, Belgium
- +55 more
Feb 2, 2021